- tags:MIGS
Research
MIGS' rising popularity is shifting glaucoma candidate demographics
New analysis finds baseline features of glaucoma patients are trending younger over the last 10 years.
Products
FDA clears Oertli's Faros anterior cataract surgery system
Latest surgical system features a compact design and offers rapid operational readiness in under 1 minute.
Business
Alcon officially acquires BELKIN Vision
Purchase involves the Israeli company’s FDA-cleared direct selective laser trabeculoplasty technology.Business
Alcon is buying Belkin Vision and its contact-less SLT glaucoma device
Acquisition is estimated to be worth up to $335 million and will close in Q3 2024.
Legal
Alcon faces penalty over Sight Sciences patent infringement
Jury trial rules that Alcon willfully infringed on three Sight Sciences patents, compelling them to pay $34 million in monetary damages.
Research
Sight Sciences reports real-world data on leading MIGS devices, including OMNI Surgical System
Large-scale, comparative study also evaluated the Hydrus Microstent and iStent inject for lowering IOP in 100,000+ glaucoma patients’ eyes.
Research
AAO panel finds potential IOP benefits to MIGS-cataract combined surgical approach
Literature search report examines RCTs involving patients with mild-to-moderate open-angle glaucoma.
Research
New 2-year MIGS data supports TCOR using the OMNI Surgical System
Real-world study examined the use of three different MIGS devices against cataract surgery alone for treating IOP.
Research